MicroRNAs (
miRNAs) are single-stranded
non-coding RNA molecules that play a regulatory role in gene expression and
cancer cell signaling. We previously identified miR-628-5p (miR-628) as a potential
biomarker in serum samples from men with
prostate cancer (PCa) (Srivastava et al. in Tumour Biol 35:4867-4873, 10.1007/s13277-014-1638-1, 2014). This study examined the detailed cellular phenotypes and pathways regulated by miR-628 in PCa cells. Since
obesity is a significant risk factor for PCa, and there is a correlation between levels of the
obesity-associated
hormone leptin and PCa development, here we investigated the functional relationship between
leptin and miR-628 regulation in PCa. We demonstrated that exposure to
leptin downregulated the expression of miR-628 and increased cell proliferation/migration in PCa cells. We next studied the effects on
cancer-related phenotypes in PCa cells after altering miR-628 expression levels. Enforced expression of miR-628 in PCa cells inhibited cell proliferation, reduced PCa cell survival/migration/invasion/spheroid formation, and decreased markers of cell stemness. Mechanistically, miR-628 binds with the JAG1-3'UTR and inhibits the expression of
Jagged-1 (JAG1). JAG1 inhibition by miR-628 downregulated Notch signaling, decreased the expression of Snail/Slug, and modulated epithelial-mesenchymal transition and invasiveness in PC3 cells. Furthermore, expression of miR-628 in PCa cells increased sensitivity towards the drugs
enzalutamide and
docetaxel by induction of cell apoptosis. Collectively our data suggest that miR-628 is a key regulator of PCa
carcinogenesis and is modulated by
leptin, offering a novel therapeutic opportunity to inhibit the growth of advanced PCa.